Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

Roche.com

More than 200 jobs set to go at Clare pharmaceutical plant

Plans announced last November to close the Roche’s Clare-based plant are going ahead after failure to secure a buyer.

HUNDREDS OF WORKERS are set to lose their jobs at a Roche pharmaceutical plant in Clare.

The company announced last year that the facility was set to close as part of a global restructuring programme, but there had been hope that the plant could be bought over by another pharmaceutical company – a move that would secured workers’ jobs.

The plant – based in the town of Clarecastle – had been in operation since 1974 and was the only facility the company has in Ireland.

There will not be an instant closure at the facility, with the 240 workers being phased out over the next three years.

The company had announced its plans to close the plant last November, when managing director of Roche Ireland Gerry Cahill said that he had not been given any advanced notice of its closure.

The company had been working alongside the IDA in its efforts to secure a buyer for the site.

In a statement last night, the company said that negotiations to transfer the services at Clarecastle to another company had been unsuccessful.

It said that production at the site will “cease in a phased approach currently estimated to be completed between 2018 and 2019 when Roche will exit the site”.

The company said that it would now be entering into a consultation with its employees and their representatives.

The international downsizing by the company has been attributed to it focusing its attention on a “new generation of specialised medicines”, which are produced in smaller volumes than medicines would have traditionally been.

Read: Job losses: Intel workers being told about ‘separation programmes’

Also: Confirmed: Intel to cut jobs in Ireland

Readers like you are keeping these stories free for everyone...
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.

Author
Michael Sheils McNamee
View 41 comments
Close
41 Comments
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.
    JournalTv
    News in 60 seconds